Synthesis and antibacterial activity of 1, 3-diaryl-4-cyanopyrazoles

O Prakash, R Pundeer, P Ranjan…

Index: Prakash, Om; Pundeer, Rashmi; Ranjan, Pooja; Pannu, Kamaljeet; Dhingra, Yogita; Aneja Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 2009 , vol. 48, # 4 p. 563 - 568

Full Text: HTML

Citation Number: 17

Abstract

Abstract: A mild, short and simple method for the small scale synthesis of pharmaceutically important 1, 3-diaryl-4-cyanopyrazoles 3 is reported from acetophenone arylhydrazones 1 through a two step reaction. All the title compounds have been subjected to in vitro antibacterial testing against four pathogenic strains namely, S. aureus, B. subtilis (gram positive) and gram negative bacteria namely, P. aeruginosa and E. coli. Preliminary ...

Related Articles:

Curcumin-I Knoevenagel's condensates and their Schiff's bases as anticancer agents: Synthesis, pharmacological and simulation studies

[Ali, Imran; Haque, Ashanul; Saleem, Kishwar; Hsieh, Ming Fa Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 13 p. 3808 - 3820]

Diaryl pyrazole-4-carbaldehyde benzoylhydrazones metal complexes: Synthesis and their antibacterial and antioxidant screening

[Nasrullah, Muhammad; Khan, Misbahul Ain; Khan, Muhammad Naeem; Humphrey, Mark G. Humphrey; Nasim, Faizul Hassan; Chaudhry, Faryal; Abidi, Moeena Ghazal; Farooq, Umar; Munawar, Munawar Ali Asian Journal of Chemistry, 2013 , vol. 25, # 1 p. 419 - 423]

Synthesis and Antimicrobial Evaluation of Some Novel 2-(4-Chlorophenylimino) thiazolidin-4-one Derivatives

[B'Bhatt; Sharma Journal of the Korean Chemical Society, 2012 , vol. 56, # 3 p. 341 - 347]

Synthesis, biological evaluation, and molecular docking studies of N, 1, 3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents

[Li, Xi; Lu, Xiang; Xing, Man; Yang, Xian-Hui; Zhao, Ting-Ting; Gong, Hai-Bin; Zhu, Hai-Liang Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 11 p. 3589 - 3593]

Synthesis, biological evaluation and molecular docking studies of 3-(1, 3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity

[Li, Xi; Liu, Jia-Lin; Yang, Xian-Hui; Lu, Xiang; Zhao, Ting-Ting; Gong, Hai-Bin; Zhu, Hai-Liang Bioorganic and Medicinal Chemistry, 2012 , vol. 20, # 14 p. 4430 - 4436]

More Articles...